Podiatrists in Jacksonville, IL Accepting Medicare
5 Podiatrists found. Showing 1 - 5
 Foot & Ankle Associates Of Central Illinois Llc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1515 W Walnut St, Suite 12, Jacksonville, IL 62650 Phone: 217-243-1101 Fax: 217-243-5003 |
 Dr. Anthony Scroggins, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1515 W Walnut St, Suite 3b, Jacksonville, IL 62650 Phone: 217-245-4610 Fax: 217-479-0169 |
 Dr. Terese J Laughlin, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1515 W Walnut St, Suite 12, Jacksonville, IL 62650 Phone: 217-243-1101 Fax: 217-243-5003 |
Mr. Jeffrey W Fleischli, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1745 W Walnut St Ste 12, Jacksonville, IL 62650 Phone: 800-532-6279 |
Peter Damon Russotto, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1440 W Walnut St, #5, Jacksonville, IL 62650 Phone: 217-243-3668 |
News Archive
Federal officials push greater medical use of gene sequencing
Almost a year after researchers in Wisconsin published a groundbreaking paper describing their use of genetic sequencing to diagnose and treat a 4-year-old boy, a national health agency is shifting its focus to put $416 million into making the secrets of our genetic script part of standard medical practice.
DTRA presents Outstanding Scientific Achievement award to Aduro BioTech
Aduro BioTech, a clinical-stage immunotherapy company, is pleased to announce the "Outstanding Scientific Achievement" award from the Defense Threat Reduction Agency. The award was presented at the 2010 Chemical and Biological Defense Science and Technology Conference in Orlando, Florida to Dr. Justin Skoble, Associate Director, Biodefense and Process Development at Aduro BioTech.
Wistar scientists discover new therapeutic strategy for difficult-to-treat form of ovarian cancer
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.
New drug combination therapy effective for patients with HER2-positive breast cancer
Combining the chemotherapy drugs docetaxel and carboplatin with the HER2-targeted therapy trastuzumab was identified to be an ideal postsurgery treatment option for patients with HER2-positive breast cancer, regardless of tumor size and whether or not disease has spread to the lymph nodes, according to results from the BETH study presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
› Verified 9 days ago
Chiropractors
Physical Therapists
Optometrists
Speech-Language Pathologists
Occupational Therapists
Podiatrists
Audiologists